Publication | Closed Access

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

OncologyGastrointestinal OncologyRegorafenib MonotherapyClinical TrialsColorectal CancerMetastatic Colorectal CancerSurgeryPharmacotherapyCancer TreatmentMedicineRadiation OncologyHealth Sciences